{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:16Z","timestamp":1793686336022,"version":"4.5.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"47","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Anti-Ro\/La autoantibodies are especially prevalent in autoimmune diseases but are also relatively frequent in healthy adults. Their arrhythmogenic effect on the immature cardiac conductive system is well established, with substantial evidence demonstrating an increased risk for congenital atrioventricular block in neonates of seropositive mothers. Despite their wide distribution and their arrhythmogenic potential effect, there are no large population studies conducted in seropositive adults. Thus, this is the first large population-based study to examine the association of anti-Ro\/La seropositivity with cardiac rhythm and conduction disturbances.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This cross-sectional designed study involved the electronic health records of the largest health maintenance organization in Israel. All subjects that were tested positive for anti-Ro\/anti-La antibodies between the years 2002 and 2019 were included and were matched by age, gender, and place of residence, with controls. Rates of different cardiac rhythm and conduction disturbances were compared between groups. Sensitivity analyses were performed using propensity score matching. The study population included 17 231 anti-Ro\/La seropositive subjects and 84 368 controls. Anti-Ro seropositive patients had higher rates of conduction disturbances (3.0 vs. 1.7%, P &amp;lt; 0.001) and rhythm disturbances (10.5 vs. 7.0%, P &amp;lt; 0.001). Patients who tested positive for anti-La alone did not demonstrate a significant association with arrhythmias. Multivariate logistic regression analysis, controlling for possible confounders, showed an increased risk for cardiac conduction disturbances [odds ratio (OR) 1.44, 95% confidence interval (CI) 1.25\u20131.66, P &amp;lt; 0.001], as well as for cardiac rhythm disturbances (OR 1.21, 95% CI 1.11\u20131.31, P &amp;lt; 0.001) among anti-Ro seropositive patients. However, the association with rhythm disturbances was more robust in certain subgroup analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Anti-Ro seropositivity is positively associated with adult cardiac conduction disturbances and, to a lesser extent, cardiac rhythm disturbances, regardless of the presence of concurrent autoimmune disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehac516","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T16:47:22Z","timestamp":1662655642000},"page":"4912-4919","source":"Crossref","is-referenced-by-count":26,"title":["Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-7302","authenticated-orcid":false,"given":"Aviram","family":"Akuka","sequence":"first","affiliation":[{"name":"Department of Medicine \u2018B\u2019, Sheba Medical Center , Tel-Hashomer 5262100 , Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University , Tel Aviv, Ramat-Aviv 69978 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4721-2003","authenticated-orcid":false,"given":"Niv","family":"Ben-Shabat","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2018B\u2019, Sheba Medical Center , Tel-Hashomer 5262100 , Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University , Tel Aviv, Ramat-Aviv 69978 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-8027","authenticated-orcid":false,"given":"Abdulla","family":"Watad","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2018B\u2019, Sheba Medical Center , Tel-Hashomer 5262100 , Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University , Tel Aviv, Ramat-Aviv 69978 , Israel"},{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds , Leeds LS2 9JT , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-6395","authenticated-orcid":false,"given":"Avishai M","family":"Tsur","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2018B\u2019, Sheba Medical Center , Tel-Hashomer 5262100 , Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University , Tel Aviv, Ramat-Aviv 69978 , Israel"},{"name":"Israel Defence Forces, Medical Corps , Tel Hashomer, Ramat Gan 52620 , Israel"},{"name":"Faculty of Medicine, Department of Military Medicine, Hebrew University of Jerusalem , Jerusalem 9190401 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Ehrenberg","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2018B\u2019, Sheba Medical Center , Tel-Hashomer 5262100 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds , Leeds LS2 9JT , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Comaneshter","sequence":"additional","affiliation":[{"name":"Chief Physician\u2019s Office, Faculty of Health Sciences, Clalit Health Services Tel Aviv, Ben Gurion University of the Negev , Beer Sheva 8410501 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9268-4766","authenticated-orcid":false,"given":"Roy","family":"Beinart","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University , Tel Aviv, Ramat-Aviv 69978 , Israel"},{"name":"Heart Institute, Chaim Sheba Medical Center , Tel Hashomer 52620 , Israel"},{"name":"Davidai Arrhythmia Center, Sheba Medical Center , Tel Hashomer 52620 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8377-9982","authenticated-orcid":false,"given":"Arnon D","family":"Cohen","sequence":"additional","affiliation":[{"name":"Chief Physician\u2019s Office, Faculty of Health Sciences, Clalit Health Services Tel Aviv, Ben Gurion University of the Negev , Beer Sheva 8410501 , Israel"},{"name":"Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev , Beer Sheva 8410501 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-7716","authenticated-orcid":false,"given":"Howard","family":"Amital","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2018B\u2019, Sheba Medical Center , Tel-Hashomer 5262100 , Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University , Tel Aviv, Ramat-Aviv 69978 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"2022121408312426300_ehac516-B1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930400022954","article-title":"Anti-Ro\/SSA and La\/SSB antibodies","volume":"38","author":"Franceschini","year":"2005","journal-title":"Autoimmunity"},{"key":"2022121408312426300_ehac516-B2","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022121408312426300_ehac516-B3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/s10165-008-0028-1","article-title":"Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period","volume":"18","author":"Hayashi","year":"2008","journal-title":"Mod Rheumatol"},{"key":"2022121408312426300_ehac516-B4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.curtheres.2014.06.004","article-title":"The prevalence of antinuclear antibodies in the general population of China: a cross-sectional study","volume":"76","author":"Guo","year":"2014","journal-title":"Curr Ther Res Clin Exp"},{"key":"2022121408312426300_ehac516-B5","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Zmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022121408312426300_ehac516-B6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.1.6173.1235","article-title":"Congenital heart block and maternal systemic lupus erythematosus","volume":"1","author":"Esscher","year":"1979","journal-title":"BMJ"},{"key":"2022121408312426300_ehac516-B7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"2022121408312426300_ehac516-B8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/acr.22370","article-title":"Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort","volume":"67","author":"Bourr\u00e9-Tessier","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022121408312426300_ehac516-B9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.RES.80.3.354","article-title":"Arrhythmogenicity of IgG and anti-52-kD SSA\/Ro affinity-purified antibodies from mothers of children with congenital heart block","volume":"80","author":"Boutjdir","year":"1997","journal-title":"Circ Res"},{"key":"2022121408312426300_ehac516-B10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrcardio.2017.61","article-title":"Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias","volume":"14","author":"Lazzerini","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2022121408312426300_ehac516-B11","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/01.CIR.103.11.1599","article-title":"Direct inhibition of expressed cardiac l- and t-type calcium channels by igg from mothers whose children have congenital heart block","volume":"103","author":"Xiao","year":"2001","journal-title":"Circulation"},{"key":"2022121408312426300_ehac516-B12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/rheumatology\/ker515","article-title":"Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus","volume":"51","author":"Llanos","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2022121408312426300_ehac516-B13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.115.009800","article-title":"Pathogenesis of the novel autoimmune-associated long-QT syndrome","volume":"132","author":"Yue","year":"2015","journal-title":"Circulation"},{"key":"2022121408312426300_ehac516-B14","first-page":"1500","article-title":"Anti-Ro52 antibody acts on the S5-pore linker of hERG to chronically reduce channel expression","volume":"115","author":"Szendrey","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2022121408312426300_ehac516-B15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-3083.2010.02428.x","article-title":"Anti-Ro\/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses","volume":"72","author":"Lazzerini","year":"2010","journal-title":"Scand J Immunol"},{"key":"2022121408312426300_ehac516-B16","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.hrthm.2011.06.032","article-title":"Autoantibodies and cardiac arrhythmias","volume":"8","author":"Lee","year":"2011","journal-title":"Heart Rhythm"},{"key":"2022121408312426300_ehac516-B17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.hrthm.2014.10.031","article-title":"Isolated atrioventricular block of unknown origin in adults and anti-Ro\/SSA antibodies: clinical evidence, putative mechanisms, and therapeutic implications","volume":"12","author":"Lazzerini","year":"2015","journal-title":"Heart Rhythm"},{"key":"2022121408312426300_ehac516-B18","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/acr.20540","article-title":"Anti-Ro\/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity","volume":"63","author":"Lazzerini","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022121408312426300_ehac516-B19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.amjcard.2007.04.048","article-title":"Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro\/SSA and connective tissue disease","volume":"100","author":"Lazzerini","year":"2007","journal-title":"Am J Cardiol"},{"key":"2022121408312426300_ehac516-B20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/acr.20470","article-title":"Prolonged corrected QT interval in anti-Ro\/SSA-positive adults with systemic lupus erythematosus","volume":"63","author":"Bourr\u00e9-Tessier","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022121408312426300_ehac516-B21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.20130","article-title":"Prolongation of the corrected QT interval in adult patients with anti-Ro\/SSA-positive connective tissue diseases","volume":"50","author":"Lazzerini","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2022121408312426300_ehac516-B22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5152\/eurjrheum.2018.18019","article-title":"Anti-Ro antibodies and complete heart block in adults with Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Jobling","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"2022121408312426300_ehac516-B23","doi-asserted-by":"crossref","first-page":"e003419","DOI":"10.1161\/CIRCEP.115.003419","article-title":"Arrhythmogenicity of Anti-Ro\/SSA antibodies in patients with Torsades de Pointes","volume":"9","author":"Lazzerini","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022121408312426300_ehac516-B24","doi-asserted-by":"crossref","first-page":"e018735","DOI":"10.1161\/JAHA.120.018735","article-title":"Risk of QTc interval prolongation associated with circulating Anti-Ro\/SSA antibodies among US veterans: an observational cohort study","volume":"10","author":"Lazzerini","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2022121408312426300_ehac516-B25","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N Engl J Med"},{"key":"2022121408312426300_ehac516-B26","first-page":"404","article-title":"Prevalence of selected chronic diseases in Israel","volume":"3","author":"Rennert","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"2022121408312426300_ehac516-B27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10067-018-4037-y","article-title":"Ischemic heart disease and ankylosing spondylitis\u2014assessing the role of inflammation","volume":"37","author":"Vinker Shuster","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2022121408312426300_ehac516-B28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.autrev.2016.01.006","article-title":"Coexistence of ischemic heart disease and rheumatoid arthritis patients\u2014a case control study","volume":"15","author":"Houri Levi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2022121408312426300_ehac516-B29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2017.02.135","article-title":"Investigating the link between ischemic heart disease and Behcet\u2019s disease: a cross-sectional analysis","volume":"241","author":"Yavne","year":"2017","journal-title":"Int J Cardiol"},{"key":"2022121408312426300_ehac516-B30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/ar1690","article-title":"Anti-SSA\/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options","volume":"7","author":"Costedoat-Chalumeau","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2022121408312426300_ehac516-B31","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.autrev.2013.04.006","article-title":"Preventing congenital neonatal heart block in offspring of mothers with anti-SSA\/Ro and SSB\/La antibodies: a review of published literature and registered clinical trials","volume":"12","author":"Gleicher","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2022121408312426300_ehac516-B32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fcvm.2019.00011","article-title":"First report of the Italian registry on immune-mediated congenital heart block (Lu.Ne Registry)","volume":"6","author":"Fredi","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"2022121408312426300_ehac516-B33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11926-007-0003-4","article-title":"Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus","volume":"9","author":"Friedman","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"2022121408312426300_ehac516-B34","doi-asserted-by":"crossref","first-page":"iv39","DOI":"10.1093\/rheumatology\/kel315","article-title":"Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases","volume":"45","author":"Seferovi\u0107","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2022121408312426300_ehac516-B35","first-page":"173","article-title":"Anti-RO anti-LA anti-RNP antibodies and eletrocardiogram\u2019s PR interval in adult patients with systemic lupus erythematosus","volume":"33","author":"Costa","year":"2008","journal-title":"Acta Reumatol Port"},{"key":"2022121408312426300_ehac516-B36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3109\/s10165-007-0631-6","article-title":"Primary biliary cirrhosis in female subjects with sicca-associated antibodies","volume":"17","author":"Takada","year":"2007","journal-title":"Mod Rheumatol"},{"key":"2022121408312426300_ehac516-B37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2014.11.002","article-title":"Anti-Ro\/SSA antibodies and cardiac rhythm disturbances: present and future perspectives","volume":"184","author":"Santos-Pardo","year":"2015","journal-title":"Int J Cardiol"},{"key":"2022121408312426300_ehac516-B38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"2022121408312426300_ehac516-B39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12016-008-8094-x","article-title":"Atherosclerosis in autoimmune rheumatic diseases\u2014mechanisms and clinical findings","volume":"37","author":"Zinger","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"2022121408312426300_ehac516-B40","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3390\/ijms19071890","article-title":"Systemic inflammatory response and atherosclerosis: the paradigm of chronic inflammatory rheumatic diseases","volume":"19","author":"Arida","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2022121408312426300_ehac516-B41","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/bmj.2.5366.1149","article-title":"The aetiology of complete heart-block","volume":"2","author":"Zoob","year":"1963","journal-title":"BMJ"},{"key":"2022121408312426300_ehac516-B42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/eurheartj\/ehu357","article-title":"High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events","volume":"36","author":"Singh","year":"2015","journal-title":"Eur Heart J"},{"key":"2022121408312426300_ehac516-B43","doi-asserted-by":"crossref","first-page":"e194176","DOI":"10.1001\/jamanetworkopen.2019.4176","article-title":"Risk factors associated with atrioventricular block","volume":"2","author":"Kerola","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2022121408312426300_ehac516-B44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780290207","article-title":"Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sj\u00f6gren\u2019s syndrome","volume":"29","author":"Harley","year":"1986","journal-title":"Arthritis Rheum"},{"key":"2022121408312426300_ehac516-B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-4-1","article-title":"Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited","volume":"4","author":"Kumar","year":"2009","journal-title":"Diagn Pathol"},{"key":"2022121408312426300_ehac516-B46","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMp038142","article-title":"Autoantibodies in systemic lupus erythematosus\u2014there before you know it","volume":"349","author":"Shmerling","year":"2003","journal-title":"N Engl J Med"},{"key":"2022121408312426300_ehac516-B47","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"2022121408312426300_ehac516-B48","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","article-title":"The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants","volume":"55","author":"Jaeggi","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/47\/4912\/47847267\/ehac516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/47\/4912\/47847267\/ehac516.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T06:58:51Z","timestamp":1671001131000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/47\/4912\/6711730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":48,"journal-issue":{"issue":"47","published-online":{"date-parts":[[2022,9,23]]},"published-print":{"date-parts":[[2022,12,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac516","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,14]]},"published":{"date-parts":[[2022,9,23]]}}}